Crispr Therapeutics shares owned by Eqis Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Eqis Capital Management
from 13F filings
Historical chart of Eqis Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Eqis Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Eqis Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $438k | 9.0k | 48.64 |
| 2025-03-31 | $324k | 9.5k | 34.03 |
| 2024-12-31 | $394k | 10k | 39.36 |
| 2024-09-30 | $383k | 8.2k | 46.98 |
| 2024-06-30 | $464k | 8.6k | 54.01 |
| 2024-03-31 | $447k | 6.6k | 68.16 |
| 2023-09-30 | $380k | 8.4k | 45.39 |
| 2023-06-30 | $509k | 9.1k | 56.14 |
| 2023-03-31 | $391k | 8.6k | 45.23 |
| 2022-12-31 | $354k | 8.7k | 40.65 |
| 2022-09-30 | $1.7M | 26k | 65.35 |
| 2022-06-30 | $778k | 13k | 60.77 |
| 2022-03-31 | $1.1M | 18k | 62.75 |
| 2021-12-31 | $1.8M | 24k | 75.78 |
| 2021-09-30 | $2.7M | 24k | 111.94 |
| 2021-06-30 | $3.5M | 21k | 161.90 |
| 2021-03-31 | $2.8M | 23k | 121.87 |